Orthopedic Biologics Supplier Serving Little Rock, AR

Vendor review for surgery centers and orthopedic groups

Larger orthopedic groups and ambulatory surgery centers in the Southeast typically run a formal vendor review before adding a new tissue or biologics supplier, covering sourcing, processing description, and lot release criteria. Many groups route that review through a compliance officer or medical director rather than a single ordering physician.

Because Wharton's jelly allografts and exosome products are regulated differently at the federal level, practices generally ask their own counsel to confirm how a specific product and intended use fit within their procedures before it is added to an ordering list.

NPI verification and account setup

An ordering account with Precision Biologics opens once a practice's NPI number has been verified. A practice administrator submits the NPI, and the account then gains access to documentation for the specific lots under consideration.

Physician-level peer-to-peer calls are available to review sourcing and paperwork questions. These calls do not cover surgical technique, dosing, or case selection.

Cold-chain logistics and documentation for Southeast practices

Cryopreserved products ship overnight on dry ice in validated containers for storage at -80 degrees Celsius on arrival; lyophilized formats are shelf-stable and ship per the insert supplied with the lot. A practice in Little Rock or elsewhere in the Southeast should have freezer capacity and a receiving procedure confirmed ahead of a first shipment, particularly during warmer months when transit conditions can vary.

A certificate of analysis, donor eligibility summary, and lot release record are provided for each lot to verified accounts. Arkansas practices should verify medical-director and oversight requirements with the Arkansas medical board and their own counsel.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.